ABC | Volume 111, Nº3, Setembro 2018

Diretrizes Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda Arq Bras Cardiol. 2018; 111(3):436-539 311. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS BLED) to asses 1-year risk of major bleeding in patients with atrial fibrillation. Chest. 2010;138(5):1093-100. 312. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al; ESC Scientific Document Group. 2016 ESCGuidelines for themanagement of atrial fibrillation developed in collaborationwith EACTS The Task Force for themanagement of atrial fibrillation of the European Society of Cardiology (ESC). EurHeart J. 2016;37(38):2893-962. 313. Magalhães LP, FigueiredoMJ, Cintra FD, Saad EB, Kuniyoshi RR, Menezes Lorga Filho A, et al. Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation. Arq Bras Cardiol. 2016;107(6):501-8. 314. Xiong Q, Lau YC, Senoo K, Lane DA, Hong K, Lip GY. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. Eur J Heart Fail. 2015;17(11):1192-200. 315. SavareseG, Giugliano RP, RosanoGM, McMurray J, Magnani G, Filippatos G, et al. Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis. JACC Heart Fail. 2016;4(11):870-80. 316. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206-14. 317. Baman TS, LangeDC, Ilg KJ, Gupta SK, Liu TY, Alguire C, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7(7):865-9. 318. Penela D, Van Huls Van Taxis C, Aguinaga L, Fernández-Armenta J, Mont L, Castel MA, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol. 2013;62(13):1195-202. 319. Nikolaidou T, JohnsonMJ, Ghosh JM, Marincowitz C, Shah S, Lammiman MJ, et al. Post-mortem ICD interrogation in mode of death classification. J Cardiovasc Electrophysiol. 2018;29(4):573-83. 320. Adabag S, Smith LG, Anand IS, Berger AK, Luepker RV. Sudden cardiac death in heart failure patients with preserved ejection fraction. J Card Fail. 2012;18(10):749-54. 321. Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, et al. Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the Sudden Cardiac Death in Heart FailureTrial. JAMA Cardiol. 2017;2(7):767-774. 322. Le HH, El-Khatib C, Mombled M, Guitarian F, Al-Gobari M, Fall M, et al. Impact of aldosterone antagonists on sudden cardiac death prevention in heart failure and post-myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2016;11(2):e0145958. 323. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, orsotalolforpreventionofshocksfromimplantablecardioverterdefibrillators: theOPTIC Study: a randomized trial. JAMA. 2006;295(2):165-71. 324. Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111-21. 325. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399-410. 326. LimaEG,CarvalhoFP,LinharesFilho JP,PittaFG,SerranoCV Jr. Ischemic left ventricle systolic dysfunction: an evidence-based approach in diagnostic tools and therapeutics. Rev AssocMed Bras (1992). 2017;63(9):793-800. 327. Trevisan L, Cautela J, Resseguier N, Laine M, Arques S, Pinto J, et al. Prevalence and characteristics of coronary artery disease in heart failure withpreservedandmid-rangeejection fractions:Asystematicangiography approach. Arch Cardiovasc Dis. 2018;111(2):109-118. 328. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al; COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-91. 329. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al; STICH Investigators. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607-16. 330. Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, et al; STICH Trial Investigators. Ten-Year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction:ananalysisoftheextendedfollow-upoftheSTICHTrial(Surgical TreatmentforIschemicHeartFailure).Circulation.2016;134(18):1314-1324. 331. Mielniczuk LM, Toth GG, Xie JX, Bruyne BD, Shaw LJ, Beanlands RS. Can functional testing for ischemia andviability guide revascularization? JACC Cardiovasc Imaging. 2017;10(3):354-64. 332. Williams MC, Hunter A, Shah AS, Assi V, Lewis S, Smith J, et al; SCOT- HEART Investigators.Useofcoronarycomputedtomographicangiography to guidemanagement of patients with coronary disease. J AmColl Cardiol. 2016;67(15):1759-68. 333. Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associatedwith false-negative cardiovascular magnetic resonance perfusion studies: a clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging. 2016;43(3):566-73. 334. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97(3):282-9. 335. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, et al. Comparison of surgical andmedical group survival in patients with left main coronary artery disease: long-term CASS experience. Circulation. 1995;91(9):2325-34. 336. VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen- year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation. 1992;86(1):121-30. 337. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311(21):1333-9. 338. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al; STICH Investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511-20. 339. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al; AmericanHeart AssociationHeart Failure and TransplantationCommittee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535-78. 340. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-10. 341. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-62. 342. Butler J,KalogeropoulosAP,GeorgiopoulouVV,Bibbins-DomingoK,Najjar SS, Sutton-Tyrrell KC, et al. Systolic blood pressure and incident heart 526